Comparison of conditional power criteria for early termination of clinical trials

DOI10.1016/S0167-9473(03)00172-5MaRDI QIDQ956934zbMATH OpenOpenAlexFDO

Authors Josef Högel, Martina Kron

Publication date 26 November 2008

Published in Computational Statistics and Data Analysis (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1016/s0167-9473(03)00172-5

zbMATH Keywords

sequential testsearly terminationconditional powerfutility stopping

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical analysis (62L10)

Recommendations

• CONDITIONAL PROBABILITY OF SIGNIFICANCE FOR EARLY STOPPING IN FAVOR OFH₀
• Two-Stage Experimental Designs: Early Stopping with a Negative Result
• Early Stopping to Accept H 0 Based on Conditional Power: Approximations and Comparisons
• Continual reassessment designs with early termination
• Evaluation of stopping rules for stochastic curtailment

Cites work

• scientific article; zbMATH DE number 1348603 (Why is no real title available?)
• A Shift Algorithm for Exact Computation in Sequential Tests with Binary Outcome
• A discrete markov chain representation of The sequential probability ratio test
• Early Stopping to Accept H 0 Based on Conditional Power: Approximations and Comparisons
• Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis
• Statistical approaches to interim monitoring of medical trials: A review and commentary
• Stochastically curtailed tests in long–term clinical trials
• Two-Stage Experimental Designs: Early Stopping with a Negative Result

Cited in

(3)

• Stochastically curtailed tests under fractional Brownian motion
• Repeated confidence intervals and prediction intervals using stochastic curtailment under fractional Brownian motion
• CONDITIONAL PROBABILITY OF SIGNIFICANCE FOR EARLY STOPPING IN FAVOR OFH₀

This page was built for publication: Comparison of conditional power criteria for early termination of clinical trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q956934)